Skip to main content

CITADEL ADVISORS LLC

Position in ANTX — AN2 Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in ANTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,607,665
+$4,076,748 QoQ
Shares Held
951,997
+513.2% QoQ
Ownership
2.52%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 66 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ANTX ranks #146 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,607,665 951,997
2026-03-31 $530,917 155,239
2025-12-31 $131,711 115,536
2025-09-30 $29,226 23,013
2025-06-30 $13,246 12,497
2024-12-31 $93,831 67,994
2024-06-30 $3,340,732 1,553,829
2024-03-31 $5,058,800 1,556,554
2023-12-31 $31,899,692 1,556,842
2023-09-30 $25,029,356 1,556,552
2023-06-30 $11,364,355 1,336,983
2023-03-31 $13,197,759 1,337,159
2022-12-31 $12,741,447 1,336,983
2022-09-30 $23,236,764 1,336,983
2022-06-30 $10,337,074 1,333,816
2022-03-31 $21,397,154 1,419,851